Stable Coronary Artery Disease clinical trials

Explore recruiting stable coronary artery disease clinical trials.

Recruiting stable coronary artery disease studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Stable Coronary Artery Disease trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Randomized, Double-Blind, Placebo-Controlled Phase IIa Trial to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of Repeated Subcutaneously Administered RBD4059 in Participants with Stable Coronary Artery Disease

Sweden

Therapeutic exploratory (Phase II) EU CTIS Study details

Pharmacodynamic Outcomes in patients with coronary artery disease undergoing Percutaneous coronary intervention treated with an individualized treatment STRATEGY (POPular STRATEGY PD)

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

A study to see how RO7763505 works and how safe it is when given to healthy people and people with stable heart disease

Netherlands

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Effect of Influenza Vaccination on Global Systemic Inflammatory Markers in Patients With Stable Coronary Artery Disease - Randomized Delayed-Start Pilot Trial

France

Therapeutic exploratory (Phase II) EU CTIS Study details

The effects of tirzepatIDE on coronAry pLaque lipid content and myocardial microvascular function in people with overweight or obesity and CORonary disease

Denmark

Phase III and phase IV (Integrated) EU CTIS Study details

Comparing high and lOw-dose asPirin with dual anTIplatelet therapy for three Months using prasUgrel and aSpirin following Coronary Artery Bypass Grafting. (OPTIMUS-CABG trial).

Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Stable Coronary Artery Disease trials by city

Stable Coronary Artery Disease in Toronto Stable Coronary Artery Disease in Vancouver Stable Coronary Artery Disease in Montreal Stable Coronary Artery Disease in Calgary Stable Coronary Artery Disease in Edmonton Stable Coronary Artery Disease in Ottawa Stable Coronary Artery Disease in Winnipeg Stable Coronary Artery Disease in Quebec City Stable Coronary Artery Disease in Hamilton Stable Coronary Artery Disease in Kitchener Stable Coronary Artery Disease in London Stable Coronary Artery Disease in Halifax Stable Coronary Artery Disease in New York Stable Coronary Artery Disease in Los Angeles Stable Coronary Artery Disease in Chicago Stable Coronary Artery Disease in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease